Ocean Biomedical, Inc.

NASDAQ:OCEA

0.0109 (USD) • At close May 9, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Omzet 000000000000000000
Kosten van de omzet 000000000000000000
Brutowinst 000000000000000000
Brutowinstmarge 000000000000000000
Onderzoek- en ontwikkelingskosten 0000.026-0.0170.3050.0280.39301.8583.1923.1983.1942.6622.66425.41300
Algemene en administratieve kosten 1.7530.7680.6820.569-0.6432.352.6524.8301.3153.7081.9124.9842.2262.67618.5260.8350.012
Verkoop- en marketingkosten 0000000000.05500000000
Verkoop-, algemene en administratieve kosten 1.7530.7680.6820.569-0.6432.352.6524.830.6141.373.7081.9124.9842.2262.67618.5260.8350.012
Overige kosten 000000-0.001-12.67700.001-0.6990.00100.002000.0490
Bedrijfskosten 1.7530.7680.6820.595-0.662.6552.685.2230.6141.376.95.118.1784.8885.3443.9390.8840.012
Bedrijfsresultaat 2.045-0.768-0.682-0.5950.66-2.655-2.68-5.223-0.614-1.37-6.9-5.11-8.178-4.888-5.34-43.939-0.884-0.012
Bedrijfsresultaat ratio 000000000000000000
Totaal overige inkomsten en kosten netto 4.417-4.76-16.55213.594-17.516-11.432-8.599-66.7051.0242.155-0.433-0.26500.002-0.0010-0.0010
Inkomen voor belasting 6.462-5.528-17.23412.999-16.856-14.087-13.028-67.4010.41-1.018-7.333-5.375-8.178-4.886-5.341-43.939-0.885-0.012
Inkomen voor belasting ratio 000000000000000000
Belastingkosten -3.301000000.66860.635-0.055-0.0270.433-0.001-0.069-0.0020.001-0.0550.001-0.047
Nettowinst 6.462-5.528-17.23412.999-16.856-14.087-13.028-128.0360.41-1.018-7.766-5.374-8.178-4.884-5.342-43.939-0.886-0.012
Nettowinstmarge 000000000000000000
WPA (Winst Per Aandeel) 0.01-0.2-0.630.480-0.53-0.49-5.160.031-0.077-0.73-0.27-3.1-0.36-0.4-1.35-0.044-0
Verwaterde WPA 0.01-0.2-0.630.480-0.53-0.49-5.160.031-0.077-0.73-0.27-3.1-0.36-0.4-1.35-0.044-0
EBITDA 0.716-5.067-16.71913.636-16.356-13.794-10.763-71.79115.292-3.607-7.284-5.359-8.178-4.888-5.34-43.939-0.884-0.012
EBITDA ratio 000000000000000000